Inhalopédia | Inhalers

Class
- Inhaled corticosteroid (ICS)
  Long-acting beta-2 agonist (LABA)
Active ingredient
- Budesonide
- Formoterol fumarate dihydrate
Device
- Turbuhaler®
Inhalers techniques and maintenance
Age
- 12 +
Typical use
- Asthma
  uncontrolled on low dose ICS (regular intake) or initial treatment (PRN intake)
Asthma management principles
- COPD
  in addition to a LAMA, when exacerbating on dual bronchodilation (LAMA/LABA)
COPD management principles
Marketed strength
- 100/6 mcg
- 200/6 mcg
Number of doses
- 120 doses
Dose indicator
- Yes | Indicator
Usual adult dosage
- PRN | 200/6 mcg – 1 inh PRN
  Low | 100/6 mcg – 2 inh BID
  Medium | 200/6 mcg – 2 inh BID
  High | 200/6 mcg – 3-4 inh BID
  Maximum daily dose: 8 inh
ICS dosing
Usual pediatric dosage
- 6-11 years
  Low | 100/6 mcg – 1 inh QD
  Medium | 200/6 mcg – 1 inh BID
  
  12-17 years
  See adult dosage
ICS dosing
Required inspiratory flow
- > 30 - 60 L/min
  Medium internal resistance (R3)
Inspiratory flows
Public coverage
- MN | Open/Regular Benefit
  All provinces except MN | Restricted Benefit with criteria
Provincial coverage criteria
Advantages
- May be taken as a rescue medication
- Same inhaler for the regular treatment and the asthmatic action plan
Disadvantages
- BID dosing
- High number of inhalations for high ICS dose
Side effects

Product monograph

Download

Symbicort®'s website

Click to learn more

Symbicort®